Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 3. Anti-influenza virus activity of BeA and oseltamivir in the mice. Mice were infected with 5×103 pfu/30 μl of influenza A/PR/8 virus, orally administered with BeA and oseltamivir for 7 days after virus infection. Mice were sacrificed at 7 days post infection, and lung sections were prepared as described in Materials and Methods. (A) Representative H&E stained samples of lung section from uninfected or influenza A/PR/8 virus-infected mice were shown at 200× magnification. Infected mice were treated with BeA or oseltamivir. (B) Pathological grade of mice which were administrated orally for 7 days after infection. **p<0.01; ***p<0.001, and n.s. for not significant.
Biomol Ther (Seoul) 2015;23:345~349 https://doi.org/10.4062/biomolther.2015.019
© Biomolecules & Therapeutics